Lifevantage (NASDAQ:LFVN) Stock Gets Price Target Cut from Freedom Broker

Lifevantage (NASDAQ:LFVN) had its price objective dropped by research analysts at Freedom Broker from $9.00 to $8.00 in a research report issued on Friday, Benzinga reports. The firm currently has a “buy” rating on the stock. Freedom Broker‘s price target would indicate a potential upside of 64.27% from the stock’s previous close.

Several other research firms also recently issued reports on LFVN. Lake Street Capital lifted their price target on Lifevantage from $5.00 to $6.00 and gave the company a “hold” rating in a research note on Friday, August 28th. Zacks Research downgraded Lifevantage from a “hold” rating to a “strong sell” rating in a report on Friday, October 16th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Lifevantage in a report on Friday, August 21st. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Lifevantage has an average rating of “Hold” and a consensus target price of $6.33.

Lifevantage Trading Down 3.4%

Shares of LFVN stock traded down $0.17 during trading hours on Friday, hitting $4.87. 95,891 shares of the company were exchanged, compared to its average volume of 213,792. Lifevantage has a 52 week low of $3.90 and a 52 week high of $11.71. The business has a 50 day moving average of $5.95 and a two-hundred day moving average of $5.86. The company has a market capitalization of $61.76 million, a PE ratio of 23.29 and a beta of 0.71.

Lifevantage (NASDAQ:LFVN) last posted its quarterly earnings data on Monday, November 9th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.01). The company had revenue of $37.12 million during the quarter, compared to the consensus estimate of $40.49 million. Lifevantage had a net margin of 1.58% and a return on equity of 16.35%. On average, research analysts forecast that Lifevantage will post 0.39 EPS for the current year.

Insiders Place Their Bets

In other Lifevantage news, insider Kristen Cunningham sold 8,901 shares of Lifevantage stock in a transaction on Monday, September 14th. The shares were sold at an average price of $6.18, for a total value of $55,008.18. Following the sale, the insider directly owned 120,162 shares in the company, valued at approximately $742,601.16. The trade was a 6.90% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 13.58% of the company’s stock.

Hedge Funds Weigh In On Lifevantage

A number of large investors have recently modified their holdings of LFVN. Bank of New York Mellon Corp increased its position in shares of Lifevantage by 11.9% during the 1st quarter. Bank of New York Mellon Corp now owns 33,547 shares of the company’s stock worth $145,000 after purchasing an additional 3,571 shares during the last quarter. Engineers Gate Manager LP grew its stake in shares of Lifevantage by 109.7% in the second quarter. Engineers Gate Manager LP now owns 27,009 shares of the company’s stock valued at $169,000 after buying an additional 14,131 shares in the last quarter. Bank of America Corp DE grew its stake in shares of Lifevantage by 24.3% in the first quarter. Bank of America Corp DE now owns 23,445 shares of the company’s stock valued at $101,000 after buying an additional 4,586 shares in the last quarter. Finally, Hsbc Holdings PLC acquired a new position in Lifevantage during the first quarter worth $51,000. 35.32% of the stock is currently owned by institutional investors and hedge funds.

Lifevantage Company Profile

LifeVantage Corporation is a health and wellness company that develops, markets and distributes dietary supplements and personal-care products. Its product portfolio is designed to support areas such as cellular health, antioxidant defenses, energy, nutrition and skin care. The company’s principal brands have included Protandim, a line of dietary supplements; TrueScience, a skin-care and wellness brand; and Petandim, products formulated for pets. LifeVantage primarily uses a direct-selling business model, distributing its products through independent sales representatives and online channels.